2015 American Transplant Congress
Long-Term Outcomes and Recurrence Risk of Four Common Primary Glomerular Diseases Following Transplantation
In the largest single center study of its kind, we assessed patient and allograft outcomes in 598 patients with the four most common causes of…2015 American Transplant Congress
Native Kidney Biopsy Does Not Predict Post Liver Transplant Renal Outcomes
Liver transplant (LT) recipients are at high risk of posttransplant renal disease but the extent of renal disease is often unrecognized in the pretransplant setting.…2015 American Transplant Congress
Donor Apolipoprotein L1 Genotype Associates With Glomerular Lesions and Graft Loss in Kidney Transplants
Medical University of South Carolina, Charleston, SC.
Introduction/Aims: Previous studies have associated donor apolipoproteinL1 (APOL1) risk genotypes with risk of graft loss among kidney transplants. APOL1 risk genotypes have also been associated…2015 American Transplant Congress
Non-Invasive Diagnosis of Post Kidney Transplant Complications by Urinary Exosomal mRNA Analysis
IntroductionMonitoring of kidney allograft status is important for the graft longevity. Conventional urinary markers are not sensitive and specific enough to diagnose graft injuries so…2015 American Transplant Congress
Glomerular Disease (GD) After Kidney Transplant (KTx): Etiologies, Risk Factors and Consequences
1Nephrology, Mayo Clinic, Rochester, MN; 2Pathology, Mayo Clinic, Rochester, MN.
Introduction. Recipients who develop KTx GD may have reduced function and higher risk of graft loss. Using protocol and clinical biopsies we sought to determine…2015 American Transplant Congress
Successful Management of Post Transplant Focal Segmental Glomerulosclerosis With Plasma Exchange and Rituximab
Background: Post-transplant Focal Segmental Glomerulosclerosis (FSGS) is associated with renal allograft loss. Currently, optimal treatment remains controversial. We propose a management protocol that includes treatment…2015 American Transplant Congress
Utility of Anti-Phospholipase A2 Receptor (Anti-PLA2R) ELISA Testing in Predicting Post-Transplant Idiopathic Membranous Nephropathy (IMN)
Backgound: IMN is frequently associated with autoantibodies to the podocyte antigen, PLA2R. Anti-PLA2R associated IMN is diagnosed by detecting PLA2R antigen within glomerular immune complexes…
- « Previous Page
- 1
- …
- 5
- 6
- 7